Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class.
Clinical toxicology (Philadelphia, Pa.) · 2016-07-22 · Case report
Abstract
BACKGROUND: In the last decade there has been a worldwide surge in the recreational abuse of novel psychoactive substances, particularly amphetamine derivatives and synthetic cannabinoids. Synthetic opioids such as AH-7921, MT-45, and U-47700, with structures distinct from those ever used therapeutically or described recreationally, have also recently emerged. CASE DETAILS: We report a patient who suffered respiratory failure and depressed level of consciousness after recreationally using a novel synthetic opioid labeled U-47700. A single dose of naloxone administered by paramedics completely reversed his opioid poisoning. Comprehensive laboratory analysis confirmed the presence of a novel synthetic opioid and excluded other drugs. The drug used appeared to have caused a false positive benzodiazepine result on the initial urine drugs of abuse panel. CONCLUSION: The case we describe of toxicity from the synthetic opioid labeled U-47700 highlights the emerging trend of novel synthetic opioid abuse.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Poisoning & substance use · Antidotes · Synthetic opioids · Naloxone
Related articles
- Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. (Drugs, 2019)
- An Emerging Synthetic Opioid in the Drug Supply: A Case of Opioid Overdose with Biological Confirmation of Cychlorphine. (J Med Toxicol, 2026)
- Prehospital Naloxone Administration Patterns during the Era of Synthetic Opioids. (Prehosp Emerg Care, 2024)
- Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl. (J Med Toxicol, 2020)
- Opioid Overdose Outbreak - West Virginia, August 2016. (MMWR Morb Mortal Wkly Rep, 2017)
- Accidental protonitazene intoxication: clinical management and detection of a novel opioid. (BMJ Case Rep, 2025)